CD34 and metabolic syndrome: MetS-related genetic/epigenetic and progenitor-cell changes, HMGA1/2 dysregulation, miR-27b activation of senescence pathways, and abnormalities in CD34+/PDGFRα+ adipogenic progenitors, may further bias adipose niches toward aberrant proliferation and differentiation (22–28).